CVX Other Income/Expenses (Net)

Chevron Corporation · Other Income/Expenses (Net)

CVX logo

CVX Other Income/Expenses (Net)

Latest reported-$2.39B
CVX TTM Other Income/Expenses (Net) (-$6.98B → -$2.39B)
High-resolution chart · PNG

CVX other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Chevron Corporation Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
-2,392,000,000
2,489,000,000
3,069,000,000
6,136,000,000
6,549,000,000
7,905,000,000
8,589,000,000
3,029,000,000
1,178,000,000
1,253,000,000
1,081,000,000
4,789,000,000
7,910,000,000
9,663,000,000
9,724,000,000
9,960,000,000
9,044,000,000
6,900,000,000
5,459,000,000
3,175,000,000
1,359,000,000
-2,474,000,000
-1,356,000,000
401,000,000
1,352,000,000
6,287,000,000
5,436,000,000
5,544,000,000
6,067,000,000
5,261,000,000
6,129,000,000
5,583,000,000
6,100,000,000
6,093,000,000
6,256,000,000
6,491,000,000
5,349,000,000
5,289,000,000
4,056,000,000
3,992,000,000
4,623,000,000
6,792,000,000
8,552,000,000
11,296,000,000
12,605,000,000
11,432,000,000
11,476,000,000
9,707,000,000
8,750,000,000
8,457,000,000
8,692,000,000
12,729,000,000
13,213,000,000
13,979,000,000
13,266,000,000
16,673,000,000
16,516,000,000
10,310,000,000
10,188,000,000
2,042,000,000
1,048,000,000
1,468,000,000
996,000,000
388,000,000
213,000,000
3,900,000,000
3,288,000,000
2,384,000,000
2,999,000,000
3,833,000,000
4,474,000,000
1,890,000,000
170,000,000
-1,475,000,000
-2,821,000,000
-9,876,000,000
-12,475,000,000
-12,536,000,000
-12,594,000,000
-11,836,000,000
-9,350,000,000
-9,329,000,000
-9,297,000,000
-8,512,000,000
-8,482,000,000
-7,455,000,000
-9,299,000,000
-3,147,000,000
-3,656,000,000
-6,464,000,000
-6,335,000,000
-6,496,000,000
-9,288,000,000
-10,127,000,000
-10,003,000,000
-16,728,000,000
-13,362,000,000
-10,695,000,000
-9,063,000,000
-7,693,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.